Is Editas Medicine, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for Editas Medicine, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The weekly RSI shows no signal, but the monthly RSI is bullish. Daily moving averages are bullish, indicating positive short-term momentum. However, the weekly KST is mildly bearish, and the monthly KST is mildly bullish, suggesting mixed signals. The Dow Theory indicates a mildly bullish stance on a weekly basis, but no trend on a monthly basis. The OBV is mildly bullish weekly but mildly bearish monthly, adding to the mixed outlook.
In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 10.70% and 9.89% respectively, compared to 1.05% and 2.33% for the index. However, over longer periods, such as the past year and beyond, the stock has underperformed significantly, with a 1Y return of -22.68% versus the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, with key indicators showing a mix of strength and weakness.